Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Tyvaso DPI274.6M36.67%
Nebulized Tyvaso159.2M21.26%
Remodulin128.3M17.13%
Orenitram113.2M15.12%
Unituxin61.1M8.16%
Adcirca7M0.93%
Other5.5M0.73%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.2B94.62%
Rest-of-World125.3M5.38%